Official recall notice

FDA DrugClass IINotable

Liraglutide Injection Recall (May 2026) – Lupin Pharmaceuticals

Product: Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur 441108, INDIA, a) 2 Pens- NDC 70748-346-02; b) 3 Pens - NDC 70748-346-03.

Recall date
2026-05-27
Category
Drug
FDA class
Class II

Why it was recalled

Hazard

Presence of particulate matter: a white thread-like structure in the cartridge

One email a week when there are new recalls. Confirm by email; unsubscribe anytime.

Product description

Presence of particulate matter: a white thread-like structure in the cartridge

Verify with the official notice →
Share:

Related Recalls

2026-09-02 · FDA_DRUG
FDA Recall: Clobetasol Propionate Cream USP, 0.05%, 60 g tube, Rx Only, Manufactured for: Lupin Pharmaceuticals,
Lupin Pharmaceuticals Inc.
2026-07-08 · FDA_DRUG
FDA Recall: prednisoLONE Acetate Ophthalmic Suspension, USP, 1%, Rx only, Sterile, a) 5 mL (NDC 70748-332-02); b
Lupin Pharmaceuticals Inc.
2026-07-08 · FDA_DRUG
FDA Recall: Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection USP, 1mg per vial, Diluent for Gl
Lupin Pharmaceuticals Inc.